Apogee Therapeutics, Inc. Common Stock (APGE) financials · $2.34B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Apogee Therapeutics, Inc. Common Stock (APGE) $2.34B cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$285.6M | -$216.9M |
| Net Income | -$255.8M | -$182.1M |
| EPS (Diluted) | -$4.22 | -$3.30 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $937.1M | $754.0M |
| Current Assets | $741.4M | $529.7M |
| Cash & Equivalents | $131.5M | $141.8M |
| PP&E | $5.69M | $1.96M |
| Total Liabilities | $33.3M | $37.2M |
| Current Liabilities | $27.9M | $28.6M |
| Retained Earnings | -$561.8M | -$305.9M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$227.4M | -$171.2M |
| CapEx | $5.15M | $1.15M |
| Investing Cash Flow | -$179.6M | -$300.5M |
| Financing Cash Flow | $396.5M | $495.1M |
| Net Change in Cash | -$10.5M | $23.5M |
| Free Cash Flow | -$232.6M | -$172.3M |
FAQ
What is APGE P/E and revenue?
Apogee Therapeutics, Inc. Common Stock (APGE) $2.34B cap.
What is APGE revenue?
APGE income-statement cache has no revenue figure yet.
Is APGE profitable?
Apogee Therapeutics, Inc. Common Stock last cached net income is -$255.8M (FY2025).
What are APGE total assets?
Apogee Therapeutics, Inc. Common Stock last cached total assets are $937.1M (FY2025).
What is APGE free cash flow?
Apogee Therapeutics, Inc. Common Stock last cached free cash flow is -$232.6M (FY2025).
Not investment advice. Cached statements, not a live tape.